Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells

Journal of the American Society of Nephrology

Volumn 8, Issue 9, 1997, Pages 1431-1436

  Amore, Alessandro ^a   Cirina, Paola ^a   Mitola, Stefania ^a   Peruzzi, Licia ^a   Bonaudo, Roberto ^a   Gianoglio, Bruno ^a   Coppo, Rosanna ^a  

^a REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CYCLIC AMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DIALYSATE; ENDOTHELIUM CELL; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASODILATATION;

EID: 0030779203     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v891431     Document Type: Article

References (33)

1. Graefe U, Milutinovich J, Follette WC, Vizzo JE, Scribner BH: Less dialysis-induced morbidity and vascular instability with bicarbonate in dialysate. Ann Intern Med 88: 322-336, 1978
2. Vincent JL, Vanherweghem JL, Degaute JP, Berré J, Dufaye P, Kahn J: Acetate induced myocardial depression during hemodialysis for acute renal failure. Kidney Int 22: 653-657, 1982
3. Novello A, Kelsch RC, Easterling RE: Acetate intolerance during hemodialysis. Clin Nephrol 5: 29-32, 1976
4. Scribner BH: Substitution of bicarbonate for acetate in the dialysate for care of a critically ill patient. Dial Transplant 6: 26-32, 1979
5. Herrero JA, Trobo JI, Torrente J, Torralbo A, Tornero F, Cruceyra A, Coronel F, Barrientos A: Hemodialysis with acetate, D-lactate and bicarbonate: A hemodynamic and gasometric study. Kidney Int 46: 1167-1177, 1994
6. Liang CS, Lowenstein JM: Metabolic control of the circulation: Effects of acetate and pyruvate. J Clin Invest 62: 1029-1038, 1978
7. Tessitore N, Schiavon R, Panzetta G, Panebianco R, Maschio G: Acetate intolerance during hemodialysis: A role for a buffer-mediated cellular ATP depletion [Abstract]. Proceedings of the 23rd Congress of the European Dialysis Transplant Association, Budapest, Hungary, July 1-4, 1986, p. 154A
8. Burnstock G: Purine receptors. First John T. Shephard Lecture. Fourth International Symposium on Vascular Smooth Muscle, Rochester, MN, 1986
9. Worcel M: Relationship between the direct inhibitory effects of hydralazine and propildazine on arterial smooth muscle contractility and sympathetic innervation. J Pharmacol Exp Ther 198: 320-330, 1978
10. Veech RL: The untoward effects of the anions of dialysis fluids. Kidney Int 34: 587-597, 1988
11. Bingel M, Lonnemann G, Koch KM, Dinarello CA, Shaldon S: Enhancement of in vitro human interleukin-1 production by sodium acetate. Lancet 1: 14-16, 1987
12. Kunz D, Muhl H, Walker G, Pfeilschifter J: Two distinct signalling pathways trigger the expression of inducible nitric oxide synthase in rat mesangial cells. Proc Natl Acad Sci USA 91: 5387-5391, 1994
13. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991
14. Kolb H, Kolb-Bachofen V: Nitric oxide: A pathogenetic factor in autoimmunity. Immunol Today 13: 157-159, 1992
15. Sanders DW: Role of nitric oxide in regulation of blood pressure. J Nephrol 5: 23-30, 1992
16. Schultz KD, Schultz K, Schultz G: Sodium nitroprusside and other smooth muscle relaxants increase cyclic GMP levels in rat ductus deferents. Nature 265: 750-751, 1977
17. Katsuki S, Arnold W, Mittal C, Murad F: Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 3: 23-35, 1977
18. Bussolino F, De Rossi M, Sica A, Colotta A, Wang JM, Boccietto E, Padura IM, Bosia A, Dejand E, Mantovani A: Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. J Immunol 147: 2122-2129, 1993
19. Williams RL, Courtneidge SA, Wagner EF: Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell 52: 121-131, 1988
20. Garlanda C, Parravicini C, Sirono M, De Rossi M, Wainstok DE, Calamanovici R, Carozzi F, Bussolino F, Colotta F, Mantovani A, Vecchi A: Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle T: Implications for the pathogenesis of opportunistic tumors. Proc Natl Acad Sci USA 91: 7291-7295, 1994
21. Ghigo D, Arese M, Todde R, Vecchi A, Silvagno F, Costamagna C, Gang Dong Q, Alessi M, Heller R, Soldi R, Trucco F, Garbarino G, Pescarmona G, Mantovani A, Bussolino F, Bosia A: Middle T antigen transformed endothelial cells exhibit an increased activity of nitric oxide synthesis. J Exp Med 181: 9-19, 1995
22. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek TD, Lee TD, Ding A, Troso T, Nathan CJ: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228, 1990
23. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064, 1992
24. Cho HJ, Xie QW, Calaycay J, Mumford RA, Swiderek KM, Lee DT, Nathan C: Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 175: 599-604, 1992
25. Nowicki JP, Duval D, Poignet H, Scatton B: Nitric oxide mediates neuronal death after focal cerebral ischemia. Eur J Pharmacol 204: 339-340, 1991
26. Matheis G, Scherman MP, Buckberg GD, Haybron DM, Young HH, Ignarro LJ: Role of L-arginine nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 262: 616-620, 1992
27. Haeffner-Cavaillon N, Cavaillon JM, Laude M, Kazatchkine M: C3a (C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. J Immunol 139: 794-799, 1987
28. Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern D: Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med 163: 1363-1375, 1986
29. Dinarello CA: Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis. Kidney Int 42[Suppl 38]: S68-S77, 1992
30. Shaldon S, Deschodt G, Branger B, Granolleras C, Baldamus CA, Koch KM, Lysaght MJ, Dinarello CA: Haemodialysis hypotension: The interleukin hypothesis. Proc Eur Dial Transplant Assoc 22: 229-243, 1985
31. Kilbourn RG, Belloni P: Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin 1, or endotoxin. J Natl Cancer Inst 82: 772-776, 1990
32. Lamas S, Michel T, Brenner BM, Marsden PA: Nitric oxide synthesis in endothelial cells: Evidence for a pathway inducible by TNF-alpha. Am J Physiol 261: C634-C641, 1991
33. Amore A, Bonaudo R, Ghigo D, Arese M, Costamagna C, Cirina P, Gianoglio B, Perugini L, Coppo R: Enhanced production of nitric oxide by blood-dialysis membrane interaction. J Am Soc Nephrol 4: 1278-1283, 1995